comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 02:12:20 - browse：782

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

hotspot

WSS

Texas Department of Public Safety speaks out on migrant abuse allegations

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Scientists grapple with ethics of stem cell research

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Hospitals struggle to profit from CAR

leisure time

comprehensive

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

US jobless claims fall again as labor market continues to flash strength

Walensky prepares to leave CDC — and Congress — behind

EF3 tornado rips through North Carolina amid extreme weather nationwide

After affirmative action ruling, medical educators look to 'holistic review'

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

The cancer drug shortage isn’t new — and neither are the solutions

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Activists slam private health insurers over coverage restrictions

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

entertainment

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Stanford president’s abrupt resignation sparks debate

Stanford president’s abrupt resignation sparks debate

Ending racial health disparities hinges on penalties, political will

Indian pharmaceutical industry in denial over drug

Mass General totes up its waste in a move to tackle climate change

knowledge

focus

hotspot

hotspot